Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In the Delta variant, these numbers were 546 (53.2%) and 480 (46.8%) and in the Omicron BA.5 variant, they were 546 (53.2%) and 480 (46.8%), respectively.Comparison of laboratory parameters between SARS-CoV-2 variants.VariablesSARS-CoV-2 variantsP-valueAlpha (n = 1022)Delta (n = 1026)Omicron BA.5 (n = 1136)Deceased/ Improved patients479/543 (46.9/53.1%)674/352 (65.7/34.3%)297/839 (26.1/73.9%) < 0.001*Mean age ± SD53.0 ± 12.758.0 ± 11.853.7 ± 12.90.128Gender (male/female)525/497 (51.4/48.6%)546/480 (53.2/46.8%)598/538 (52.6/47.4%)0.692ALT, IU/L (mean ± SD) (Reference range: up to 41)38.5 ± 24.840.8 ± 24.735.8 ± 24.20.001AST, IU/L (mean ± SD) (Reference range: up to 38)34.9 ± 15.534.5 ± 14.031.9 ± 14.4 < 0.001*ALP, IU/L (mean ± SD) (Reference range: 90 to 450)190.2 ± 84.7188.6 ± 74.0177.2 ± 83.5 < 0.001*Cholesterol, mg/dL (mean ± SD) (Reference range: up to 200)116.1 ± 34.1120.5 ± 40.5123.1 ± 39.4 < 0.001*TG, mg/dL (mean ± SD) (Reference range: up to 200)124.1 ± 54.9121.6 ± 48.8126.9 ± 55.90.245LDL, mg/dL (mean ± SD) (Reference range: up to 150)82.8 ± 45.185.3 ± 45.3104.7 ± 48.3 < 0.001*HDL, mg/dL (mean ± SD) (Reference range: 35 to 70)32.5 ± 11.332.1 ± 11.533.6 ± 11.70.039*WBC, 109/L (mean ± SD) (Reference range: 4000 to 10,000)7627.3 ± 2843.27599.2 ± 2715.77704.9 ± 2807.70.297CRP, mg/L (mean ± SD) (Reference range: < 10 mg/L Negative)61.6 ± 21.563.9 ± 22.060.2 ± 21.70.122ESR, mm/1st h (mean ± SD) (Reference range: 0 to 15)50.1 ± 16.052.3 ± 16.049.1 ± 16.10.025FBS, mg/dL (mean ± SD) (Reference range: 70 to 100)107.1 ± 41.6109.8 ± 43.2106.5 ± 40.70.716Platelets × 1000/cumm (mean ± SD) (Reference range: 140,000 to 400,000)184 ± 71185 ± 74184 ± 690.994Uric acid, mg/dL (mean ± SD) (Reference range: 3.6 to 6.8)4.8 ± 1.84.4 ± 1.75.2 ± 1.8 < 0.001*Creatinine, mg/dL (mean ± SD) (Reference range: 0.6 to 1.4)0.9 ± 0.31.0 ± 0.30.8 ± 0.3 < 0.001*qPCR Ct value20.1 ± 6.417.4 ± 6.121.9 ± 6.0 < 0.001*25-hydroxy vitamin D, ng/mL (mean ± SD) (Sufficiency: > 30)24.2 ± 12.821.8 ± 10.333.0 ± 13.40.029*ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase, TG triglyceride, LDL low density lipoprotein, HDL high density lipoprotein, WBC white blood cells, CRP C-reactive protein, ESR erythrocyte sedimentation rate, FBS fasting blood glucose, SD standard deviation, SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2.*Statistically significant (< 0.05).

Source: Baseline clinical features and demographics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

From 14,117 patients who visited a hospital of Ilam University of Medical Sciences between November 2020 to February 2022 during the three peaks (Alpha, Delta, and Omicron BA.5) of the SARS-CoV-2 infection, 3184 patients were selected based on the following criteria: (1) having a positive real-time reverse transcription polymerase chain reaction (rtReal time-PCR) from the pharyngeal swab samples that were selected from a hospital; (2) giving informed consent to participate in the study; (3) having Iranian nationality with the same ethnicity; (4) lack of underlying comorbidities including pulmonary infection (cystic fibrosis, chronic obstructive pulmonary disease, and asthma), liver disease, chronic kidney disease, heart disease (cardiovascular disease, heart failure, and etc.), cancer, immunocompromised disease (transplant patients and human immunodeficiency virus), hypertension, pregnancy, and diabetes.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of ApaI rs7975232 and BsmI rs1544410 in clinical outcomes of COVID-19 patients according to different SARS-CoV-2 variants

Study design awaiting verification · Scientific Reports · 2023

Original publication title

Association of ApaI rs7975232 and BsmI rs1544410 in clinical outcomes of COVID-19 patients according to different SARS-CoV-2 variants

Ayad Naji Radha Al-Gharrawi; Enayat Anvari; Abolfazl Fateh

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

A growing body of research has shown how important vitamin D is in the prognosis of coronavirus disease 19 (COVID-19). The vitamin D receptor is necessary for vitamin D to perform its effects, and its polymorphisms can help in this regard. Therefore, we aimed to evaluate whether the association of ApaI rs7975232 and BsmI rs1544410 polymorphisms in different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants were influential in the outcomes of COVID-19. The polymerase chain reaction-restriction fragment length polymorphism method was utilized to determine the different genotypes of ApaI rs7975232 and BsmI rs1544410 in 1734 and 1450 patients who had recovered and deceased, respectively.

Our finding revealed that the ApaI rs7975232 AA genotype in the Delta and Omicron BA.5 and the CA genotype in the Delta and Alpha variants were associated with higher mortality rate. Also, the BsmI rs1544410 GG genotype in the Delta and Omicron BA.5 and the GA genotype in the Delta and Alpha variants were related to a higher mortality rate. The A-G haplotype was linked with COVID-19 mortality in both the Alpha and Delta variants. The A-A haplotype for the Omicron BA.5 variants was statistically significant.

In conclusion, our research revealed a connection between SARS-CoV-2 variants and the impacts of ApaI rs7975232 and BsmI rs1544410 polymorphisms. However, more research is still needed to substantiate our findings.

Authors’ abstract

A growing body of research has shown how important vitamin D is in the prognosis of coronavirus disease 19 (COVID-19). The vitamin D receptor is necessary for vitamin D to perform its effects, and its polymorphisms can help in this regard. Therefore, we aimed to evaluate whether the association of ApaI rs7975232 and BsmI rs1544410 polymorphisms in different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants were influential in the outcomes of COVID-19. The polymerase chain reaction-restriction fragment length polymorphism method was utilized to determine the different genotypes of ApaI rs7975232 and BsmI rs1544410 in 1734 and 1450 patients who had recovered and deceased, respectively.

Our finding revealed that the ApaI rs7975232 AA genotype in the Delta and Omicron BA.5 and the CA genotype in the Delta and Alpha variants were associated with higher mortality rate. Also, the BsmI rs1544410 GG genotype in the Delta and Omicron BA.5 and the GA genotype in the Delta and Alpha variants were related to a higher mortality rate. The A-G haplotype was linked with COVID-19 mortality in both the Alpha and Delta variants. The A-A haplotype for the Omicron BA.5 variants was statistically significant.

In conclusion, our research revealed a connection between SARS-CoV-2 variants and the impacts of ApaI rs7975232 and BsmI rs1544410 polymorphisms. However, more research is still needed to substantiate our findings.

Publication and source details

Original title: Association of ApaI rs7975232 and BsmI rs1544410 in clinical outcomes of COVID-19 patients according to different SARS-CoV-2 variants

Ayad Naji Radha Al-Gharrawi; Enayat Anvari; Abolfazl Fateh

Scientific Reports · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:40:27.792735+00:00

DOI: 10.1038/s41598-023-30859-7 · PMC9983525